POSC

$1.70+3.03%visit website

POSITRON CORP

Market Cap

$56M

Live price × SEC shares (Aug 14, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

0.65

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Dec 2025 · negative earnings

P/S (TTM)

121.0

TTM to Dec 2025 · revenue

P/B

38.7

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Mar 2025 Mar 31, 2025	Jun 2025 Jun 30, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	119	120	111	112
Cost of revenue	377	402	638	377
Gross profit	(258)	(282)	(527)	(265)
Operating income	(1,477)	(1,170)	(1,365)	(804)
Interest expense	34.9	29.9	23.3	21.8
Net income	(1,512)	(1,191)	(1,378)	(821)
EPS (basic) ($)	(0.05)	(0.04)	(0.04)	(0.03)	(0.32)
EPS (diluted) ($)	(0.05)	(0.04)	(0.04)	(0.03)	(0.32)
Weighted avg. shares (basic)	29,125	31,305	32,833	32,849
Weighted avg. shares (diluted)	29,125	31,305	32,833	32,849

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 22 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

4 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Oct 2, 2026 accepted 8:54 PM ET	1.01Material agreement2.03New debt obligation3.02Unregistered equity sale	Document SEC ↗
Aug 18, 2026 accepted 8:48 PM ET	1.01Material agreement	Document SEC ↗
Dec 30, 2025 accepted 9:30 PM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗
Dec 16, 2025 accepted 3:21 PM ET	4.01Auditor change	Document SEC ↗